A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)

Summary

This is a Phase II, randomized, placebo-controlled, double-blind, crossover study to evaluate the effect of multiple oral doses of CST-103 in the presence of CST-107 on Freezing of Gait (FOG) symptoms in subjects with Parkinson's Disease (PD).

Timeline

Start

2024-06

Primary completion

2024-12

Completion

2025-03

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications